Stocks and Investing Stocks and Investing
Wed, September 21, 2022
Tue, September 20, 2022
Mon, September 19, 2022
Fri, September 16, 2022
Thu, September 15, 2022
Wed, September 14, 2022

Matthew Harrison Maintained (AKRO) at Hold with Increased Target to $30 on, Sep 14th, 2022


Published on 2024-10-27 23:00:45 - WOPRAI, Matthew Harrison
  Print publication without navigation


Matthew Harrison of Morgan Stanley, Maintained "Akero Therapeutics, Inc." (AKRO) at Hold with Increased Target from $26 to $30 on, Sep 14th, 2022.

Matthew, nor any peers, have made any analyst calls on AKRO in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30